FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 319:605-607 September 8, 1988 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Over a five-year period, we measured concentrations of gut hormones in plasma samples from 353 patients in whom diagnoses of pancreatic endocrine tumors were subsequently confirmed. A median of 19 months (range, 7 to 120) after the initial diagnosis, 24 of these patients (6.8 percent) had elevated concentrations of other hormones in association with new clinical symptoms. In 13 of these patients (8 with glucagonomas, 3 with tumors secreting vasoactive intestinal polypeptide, and 2 with insulinomas), hypergastrinemia developed along with the clinical features of a gastrinoma; 5 patients died of gastrointestinal perforation or bleeding, apparently caused by this second tumor. We conclude that patients with pancreatic endocrine tumors, regardless of their initial clinical picture, require continued surveillance for new elevations of hormones.

Source Information

Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.

This article has been cited by other articles:

• Cassier, P. A, Abou-Amara-Olivieri, S., Artru, P., Lapalus, M.-G., Riou, J.-P., Lombard-Bohas, C. (2008). Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two cases.. Eur J Endocrinol 158: 935-938 [Abstract] [Full Text]  
• Kazanjian, K. K., Reber, H. A., Hines, O. J. (2006). Resection of Pancreatic Neuroendocrine Tumors: Results of 70 Cases. Arch Surg 141: 765-770 [Abstract] [Full Text]  
• Miehle, K., Tannapfel, A., Lamesch, P., Borte, G., Schenker, E., Kluge, R., Ott, R. A., Wiechmann, V., Koch, M., Kassahun, W., Paschke, R., Koch, C. A. (2004). Pancreatic Neuroendocrine Tumor with Ectopic Adrenocorticotropin Production upon Second Recurrence. J. Clin. Endocrinol. Metab. 89: 3731-3736 [Abstract] [Full Text]  
• House, M. G., Yeo, C. J., Schulick, R. D. (2002). Periampullary Pancreatic Somatostatinoma. Ann. Surg. Oncol. 9: 869-874 [Abstract] [Full Text]  
• Holdcroft, A. (2000). Hormones and the gut. Br J Anaesth 85: 58-68 [Full Text]  
• German, M S, Wang, J, Chadwick, R B, Rutter, W J (1992). Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex.. Genes Dev. 6: 2165-2176 [Abstract]  
• Stein, R. C (1989). Nonmetastatic manifestations of malignancy: hormonal. Palliat Med 3: 189-196 [Abstract]